Delivery Order SPE2DB20D2002-SPE2DB25FL72S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Priorix vials, valued at $35,329.70. This firm fixed-price delivery order, which is expected to be completed by July 23, 2025, was issued without a set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $80,289.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials. This competitively awarded, non-set-aside contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella (MMR) vaccine used across military and federal healthcare systems. This...
- The Defense Logistics Agency awarded a $1,694.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of September 4, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $27,668.94 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Priorix vials with a completion deadline of August 4, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $2,206.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Priorix vials on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $18,169.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Priorix vials with a completion date of July 24, 2025. This competitively awarded, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a $1,755.30 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Priorix vials, a measles, mumps, and rubella vaccine product. This firm fixed-price contract, with a completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $24,753 to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Priorix is a vaccine product, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. This...
- The Defense Logistics Agency awarded a $24,753.00 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Priorix vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $13,861.68 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Priorix vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL72SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Priorix vials valued at $70,715.19. This firm fixed-price contract represents a non-competitive award with an ultimate completion date of September 4, 2025, and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella (MMR) vaccine commonly used in military and federal healthcare systems for immunization programs supporting troops and beneficiaries globally. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established position as a critical federal pharmaceutical distributor demonstrates its capability to fulfill time-sensitive medical procurement requirements across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $70.7k | 9/3/25 |